Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Leukoplakia, Oral × Fluorouracil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 65 Rectal Neoplasms 37 Colonic Neoplasms 30 Pancreatic Neoplasms 29 Neoplasms 26 Stomach Neoplasms 22 Neoplasm Metastasis 20 Esophageal Neoplasms 15 Carcinoma, Non-Small-Cell Lung 15 Unspecified Adult Solid Tumor, Protocol Specific 12 Head and Neck Neoplasms 12 Breast Neoplasms 9 Adenocarcinoma 9 Squamous Cell Carcinoma of Head and Neck 8 Ovarian Neoplasms 7 Lung Neoplasms 7 Solid Tumor 5 Gallbladder Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Carcinoma, Renal Cell 5 Peritoneal Neoplasms 4 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Liver Neoplasms 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Digestive System Neoplasms 4 Cholangiocarcinoma 4 Carcinoma, Pancreatic Ductal 4 Carcinoma, Hepatocellular 4 Bile Duct Neoplasms 4

Interventions

Photochemotherapy 1 Gene Expression Profiling 1 Fluorouracil 1 Biopsy 1 Aspirin 1 Aminolevulinic Acid 1 1-phenyl-3,3-dimethyltriazene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05505539 2022-09-22

OL_5FU

University of California, San Francisco

Phase 1 Withdrawn

Leukoplakia, Oral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡